Cargando…

A Patient with Transverse Colon Cancer Complicated by Cowden Syndrome Administered FOLFOXIRI + Bevacizumab Therapy

Cowden syndrome is characterized by several clinical features related to tumorous lesions primarily consisting of systemic hamartomas. The mutation of a tumor suppressor gene, the PTEN gene, is etiologically involved. As gastrointestinal lesions, polyps of all digestive tracts involving the esophagu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takehara, Kazuhiro, Ishizaki, Yoichi, Nagakari, Kunihiko, Ohuchi, Masakazu, Fukunaga, Masaki, Sakamoto, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Single Case
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891847/ https://www.ncbi.nlm.nih.gov/pubmed/36742094 http://dx.doi.org/10.1159/000529001

Ejemplares similares

Laparoscopic Triple Segmental Bowel Resection for Endometriosis Revealed by Rectal Obstruction during Infertility Treatment
por: Nagakari, Kunihiko, et al.
Publicado: (2022)

Transabdominal preperitoneal repair using barbed sutures for bilateral inguinal hernia in liver cirrhosis with ascites
por: Ohuchi, Masakazu, et al.
Publicado: (2019)

Superior Mesenteric Artery Syndrome Improved by Enteral Nutritional Therapy according to the Controlling Nutritional Status Score
por: Takehara, Kazuhiro, et al.
Publicado: (2017)

FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer
por: Cervantes, A., et al.
Publicado: (2023)

Ascending Colon Cancer Associated with Dermatomyositis Which Was Cured after Colon Resection
por: Kamiyama, Hirohiko, et al.
Publicado: (2016)

Early Postendoscopic Transverse Colo-Colonic Intussusception
por: He, Harry, et al.
Publicado: (2020)

Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
por: Latenstein, Anouk E.J., et al.
Publicado: (2017)

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2015)

Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review
por: Walter, H, et al.
Publicado: (2013)

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
por: Sunakawa, Yu, et al.
Publicado: (2018)

Successful Laparoscopy-Assisted Resection of the Descending Colon in a Patient with Multiple Large Renal Cysts and Stricture of the Colon due to Ischemic Colitis
por: Maeda, Hiromichi, et al.
Publicado: (2018)

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
por: Antoniotti, Carlotta, et al.
Publicado: (2022)

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
por: Loupakis, F, et al.
Publicado: (2013)

Cases of low anterior resection and ileostomy for rectal cancer that required more than 18 months for stoma closure
por: Kojima, Yutaka, et al.
Publicado: (2019)

Whole Genome Sequencing Analysis of a Stage IV Colon Cancer Patient with a 10-Year Disease-Free Survival following Systemic Chemotherapy/Bevacizumab
por: Yeatman, Timothy J., et al.
Publicado: (2018)

Massive Upper and Lower GI Bleed from Simultaneous Primary (AL) Amyloidosis of the Stomach and Transverse Colon in a Patient with Multiple Myeloma
por: Khan, Zubair, et al.
Publicado: (2017)

Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'
por: Bibeau, F, et al.
Publicado: (2013)

Metastatic colon cancer derived from a diverticulum incidentally found at herniorrhaphy: a case report
por: Kimura, Jiro, et al.
Publicado: (2018)

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2011)

Reply: Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'
por: Schirripa, M, et al.
Publicado: (2013)

A Progressive Huge Accessory Spleen in the Greater Omentum
por: Matsuzawa, Hirokazu, et al.
Publicado: (2019)

Colonic Endoscopic Submucosal Dissection for a Granular Cell Tumor with Insufficient Endoscopic Manipulation in the Hepatic Flexure
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

The Skin in Cowden Syndrome
por: Lim, Agnes, et al.
Publicado: (2021)

Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study
por: Huang, Chunlong, et al.
Publicado: (2021)

Repeated Enterocutaneous Fistula in a Munchausen Syndrome Patient
por: Hagiwara, Toshiaki, et al.
Publicado: (2019)

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
por: Stein, Alexander, et al.
Publicado: (2012)

Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab
por: Li, Shenglin, et al.
Publicado: (2023)

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
por: Xu, Wei, et al.
Publicado: (2016)

Case of Incarcerated Femoral Hernia Treated with Laparoscopic Surgery after Groin Hernia Repair
por: Tsuchiya, Yuki, et al.
Publicado: (2021)

Calciphylaxis Presenting with Various Symptoms: A Case Report
por: Miura, Shinpei, et al.
Publicado: (2017)

Postpolypectomy Intramural Colonic Hematoma: The Conservative Management of a Potentially Fatal Complication
por: Mankoo, Ravinder, et al.
Publicado: (2017)

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
por: Aranda, Enrique, et al.
Publicado: (2020)

Clinical benefits of FOLFOXIRI combined with bevacizumab for advanced-stage primary signet ring cell carcinoma of the appendix: A case report
por: Huang, Nana, et al.
Publicado: (2023)

Mucocutaneous manifestations of Cowden's syndrome
por: Reddy, Kundoor Vinay Kumar, et al.
Publicado: (2016)

Multiple Meningiomata in Cowden Syndrome
por: Aggarwal, Vishal, et al.
Publicado: (2020)

Characteristics of Small Bowel Polyps Detected in Cowden Syndrome by Capsule Endoscopy
por: Saito, Keita, et al.
Publicado: (2015)

Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
por: Tilgase, Andra, et al.
Publicado: (2018)

Castleman's Disease Arising from the Hepatoduodenal Ligament Mimicking a Duodenal Gastrointestinal Stromal Tumor
por: Oishi, Koichi, et al.
Publicado: (2021)

Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension
por: Bertoli, Luigi F., et al.
Publicado: (2017)

Colonic Dilatation Complicating Acute Severe Ulcerative Colitis Managed Successfully with Accelerated Infliximab Dosing
por: Bui, Hoang Huu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cmoarlhk3d2kpuocqehh281o9k